Daiwa Securities Group Inc. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 156 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$60.0%5730.0%0.00%
Q2 2023$60.0%5730.0%0.00%
Q1 2023$6
-14.3%
5730.0%0.00%
Q4 2022$7
-99.9%
5730.0%0.00%
Q3 2022$6,000
-14.3%
5730.0%0.00%
Q2 2022$7,000
+16.7%
573
+19.9%
0.00%
Q1 2022$6,0000.0%4780.0%0.00%
Q4 2021$6,000
-14.3%
478
-14.3%
0.00%
Q3 2021$7,000
+75.0%
558
+85.4%
0.00%
Q2 2021$4,000
+33.3%
3010.0%0.00%
Q1 2021$3,0000.0%3010.0%0.00%
Q4 2020$3,000
-62.5%
301
-66.0%
0.00%
Q3 2020$8,000
-11.1%
8850.0%0.00%
Q2 2020$9,0000.0%8850.0%0.00%
Q1 2020$9,000
-25.0%
8850.0%0.00%
Q4 2019$12,000
+50.0%
885
-10.0%
0.00%
Q3 2019$8,000
-27.3%
9830.0%0.00%
Q2 2019$11,0000.0%9830.0%0.00%
Q1 2019$11,000
+37.5%
983
+31.4%
0.00%
Q4 2018$8,000
-42.9%
7480.0%0.00%
Q3 2018$14,0000.0%7480.0%0.00%
Q2 2018$14,000
+16.7%
7480.0%0.00%
Q1 2018$12,0007480.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders